Globally women MPs on the rise, but not in India

July 8, 2012

fair_MP

New Delhi, July 8: Here's one area where India is at variance with the global trend. While worldwide more women are calling the shots in parliaments and shaping laws, in India the growth in the number of women legislators has virtually been flat. Here are the numbers. Globally, there has been a 75% increase in the number of women parliamentarians in the seven-year period between 1995 and 2012. But India, where our male MPs have doggedly nixed all attempts to bring in women's reservation in Parliament, in a 11-year period between 1991 and 2012 their presence has gone up marginally from 9.7% to 10.96%.

According to the Millennium Development Goals Report 2012, released by the United Nations, while 11.3% of seats were held by women worldwide in 1995, the number had increased to 19.7% by 2012. Despite 15 general elections, the number in India is much lower.

As on November 2011, India, the world's largest democracy, has only 60 women representatives out of 544 members in Lok Sabha while there are 26 female MPs in the 241-member Rajya Sabha. According to data released by Inter parliamentary union (IPU), India ranks 98 in the world for proportion of parliament seats held by women.

UN's MDG Goals report adds that although the number of countries with women as head of government, head of state or both has more than doubled since 2005, in absolute terms the number - 17 - remains rather modest. The percentage of women ministers worldwide also improved only slightly, from 14.2% in 2005 to 16.7% in 2012.

Across the world, the most common ministerial portfolios held by women ministers have tended to be in social affairs, family and youth, women's affairs or education. According to the UN, the use of special measures or quotas were an important factor helping women to enter parliaments. Of the 59 countries that held elections in 2011 for lower or single houses, 26 had implemented special measures favouring women, and electoral quotas were used in 17. Where quotas were used, women took 27.4% of seats as opposed to 15.7% of seats in countries without any form of quota.

UN says "While trends point to an increase in women's parliamentary representation, the rate of representation remains low overall and progress is spread unevenly. The highest level is found in the Nordic countries, especially following recent gains in Denmark and Finland. Among developing regions, Latin America and the Caribbean continue to rank the highest, with a 23% average." Sub-Saharan Africa holds the second-highest regional ranking in women's representation in parliaments, 20%. Progress here was sustained thanks to the existence of quotas — mainly reserved seats. In Asia, women made gains in only one country — Thailand in the 2011 elections.

More than a third of the countries with 30% or more women MPs are in transition from conflict. Women are elected in greater numbers in systems of proportional representation than they are in majority electoral systems. The data collected on elections in 2011 indicates that women were not vying for seats in sufficient numbers to make a large electoral impact. But notably, once they run for office, they are elected at about the same rate as men.

Times View

The gender skew in Indian Parliament is something that needs to be corrected. Quite clearly, the figures here build a strong case for reservation for women in legislatures. Parties say that they don't put up more women as candidates because their 'winnability' is poor. This is a specious argument. First, if it were true, it actually makes the case for reservation stronger since that would ensure that their winnability is assured in at least one-third of the constituencies. Secondly, how does that account for the fact that even in the Rajya Sabha, where only MLAs and not the general public vote, women constitute only about 10%?


Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
January 28,2020

New Delhi, Jan 28: Kolkata Metro Rail Corp expects to complete its East-West project, which runs partly under the city’s iconic Hooghly river, by March 2022 after a delay of several years doubled costs.

The authority is awaiting a final installment of Rs 20 crore ($2.8 million) over the next two years from the Indian Railway Board, said Manas Sarkar, managing director at KMRC. A soft loan of Rs 4,160 crore from Japan International Cooperation Agency helps fund 48.5% of the project.

India’s oldest metro, which started in 1984 with a North-South service, was due to expand by 2014 but faced problems including squatters on the planned route. These issues have contributed to the total project cost rising to about Rs 8,600 crore for some 17 kilometers from Rs 4,900 crore for 14 km.

“About 40% of total transport demand will be tackled by these two metro services,” Sarkar said in an interview at his office in Kolkata. “It will be a relief for environmental pollution and the city should be much more decongested.”

The new line is expected to carry about 900,000 people daily, -- roughly 20% of the city’s population -- and will take less than a minute to cross a 520-meter underwater tunnel. Depending on the time of day, it takes some 20 minutes to use the ferry and anywhere upward of an hour to cross the Howrah bridge.

KMRC will repay the JICA loan over 30 years after an initial six-year moratorium. The interest rate is between 1.2% to 1.6%. The East-West metro project is 74% owned by the railway ministry and 26% by the ministry of housing and urban affairs.

“We don’t anticipate any further cost escalation now,” Sarkar said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 25,2020

New Delhi, Jun 25: After the Drug Controller General of India (DCGI) given its approval to manufacture and market the generic version of COVID-19 drug Remdesivir, COVIFOR, Hyderabad-based drugmaker Hetero Limited has delivered the first set of 20,000 vials in two equal lots of 10,000 each across 5 states.

The first batch, which is being marketed under the brand name of COVIFOR, was delivered to Maharashtra, Delhi, Gujarat Tamil Nadu and Hyderabad. Hetero has set a target to produce one lakh vials of the drug in two-three weeks.

The other lot would be supplied to Kolkata, Indore, Bhopal, Lucknow, Patna, Bhubaneshwar, Ranchi, Vijayawada, Cochin, Trivandrum and Goa within a week to meet the emergency requirements.

Managing director of Hetero Healthcare M Srinivasa Reddy said “the launch of Covifor in the country is a milestone in addressing public health emergencies. Through Covifor, we hope to reduce the treatment time of a patient in a hospital thereby reducing the increasing pressure on the medical infrastructure overburdened ue to accelerating COVID-19 infection rates," he said as reported by news agency.

"We are closely working with the government and the medical community to make Covifor quickly accessible to both public and private healthcare settings across the country”, Reddy said.

Covifor is a generic brand of Remdesivir which is used for the treatment of COVID-19 in adults and children hospitalised with strong symptoms of the disease. The Health Ministry had, on June 13, recommended the use of anti-viral drug Remdesivir in moderate stage of COVID-19.

Dr Reddys Laboratories and Hetero are among others which have separately entered into non-exclusive licensing agreements with the original drug-maker Gilead Sciences Inc to register, make and sell the investigational drug Remdesivir in India and other countries.

Remdesivir would be made in the company's formulation facility in Hyderabad, which has been approved by global regulatory authorities such as US Food and Drug Administration (USFDA) and EU, among others, Hetero had earlier said.

The treatment first showed improvement in trials on coronavirus patients and was approved for emergency use in severely ill patients in the United States and South Korea.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
July 30,2020

New Delhi, Jul 30: Even as COVID-19 cases continue to surge in various parts of India, more than 1 million people have recovered and discharged till now, informed Rajesh Bhushan, Secretary, Ministry of Health, here on Thursday.

"More than 1 million people have recovered from COVID-19 in the country. This landmark recovery has been achieved because of the selfless work and dedication of our doctors, nurses and frontline workers," Bhushan said at a press conference.

Giving the number of cured persons, Bhushan said, "More than 1,020,000 patients have recovered. They have been discharged. It is a great achievement."

He said, "The recovery rate has shown positive trends. It was 7.85 per cent in April and today it is 64.4 per cent, which is another heartening news which tells us that whatever battle is put by the Union government in collaboration with state governments is showing results."

"Sixteen states of the country have a recovery rate that is more than the national average. Of these, Delhi has a recovery rate of 88 per cent, Ladakh 80 per cent, Haryana 78 per cent, Assam 76 per cent, Telangana 74 per cent, Tamil Nadu & Gujarat 73 per cent, Rajasthan 70 per cent, Madhya Pradesh 69 per cent and Goa 68 per cent," Bhushan said.

He said effective clinical management lead to a decrease in case fatality rate. In June it was 3.33 per cent and now 2.21 per cent.

Bhushan said the case fatality rate in India today is 2.21 per cent and it's among the lowest in the world. Twenty-four states and Union Territories have lesser fatality rate than that of the country.

Herd immunity in a country of the size and population of India can not be a strategic option. It can only be achieved through immunisation.

"Over 18,190,000 tests have been conducted in the country including RT-PCR and rapid antigen tests. There has been a week-on-week increase in average tests per day. India is conducting 324 test per 10 lakhs population per day," Bhushan said.

He added, three vaccine candidates, are in phase 3 clinical trial. These three are in the US, UK and China. In India, two indigenously developed vaccine candidates are in phase I and II of clinical trials. 

Trial of the first vaccine involves 1,150 subjects at eight sites, second on 1,000 subjects at five sites.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.